ADEA Provides Update on Opioid Legislation
ADEA is tracking more than 150 bills in 33 states that would place restrictions on the prescribing of opioid medications.
The American Dental Education Association (ADEA) is tracking more than 150 bills in 33 states that would place restrictions on the prescribing of opioid medications.
While most of this legislation is still in the early stages of the legislative process, several trends have emerged. Among the more prevalent trends this year are bills that would require counseling patients on risks before prescribing an opioid (introduced in nine states: KY, MA, MS, MT, NH, NJ, NM, NY, and VA), impose limitations on the amount of opioids that may be prescribed (introduced in seven states: MO, MS, MT, NJ, NY, PA, and VT), and requirements for electronic prescribing (introduced in five states: CO, IN, MO, MT, and NJ).
While none of the opioid bills tracked by ADEA have passed legislatures yet, several have passed at least one chamber of a state’s legislature.
- New Mexico’s SB 221 would implement patient counseling requirements
- In Missouri, the only state without a prescription drug monitoring program (PDMP), HB 188 passed the state House and would implement a PDMP to monitor Schedule II through V controlled substances
- In Montana, HB 86 would implement a number of changes to prescribing practices, including a 7-day limitation on initial opioid prescriptions to opioid naïve patients and mandatory use of the state’s PDMP under certain circumstances, while SB 61 would require prescribing practitioners to register with the state’s PDMP.
- Colorado’s SB 79 would require the use of electronic prescriptions for all Schedule II through V Controlled Substances.
- Wyoming’s SF 46 would prohibit opioid prescriptions greater than a 14-day supply, in a 14 day-period, for opioid naïve patients.